21 results
424B3
ALVO
Alvotech
21 Sep 22
Prospectus supplement
4:59pm
effects could affect patient recruitment for clinical trials, the ability of enrolled patients to complete Alvotech’s studies or result in potential
424B3
ALVO
Alvotech
21 Sep 22
Prospectus supplement
4:54pm
affect patient recruitment for clinical trials, the ability of enrolled patients to complete Alvotech’s studies or result in potential product
F-1/A
ALVO
Alvotech
14 Sep 22
Registration statement (foreign) (amended)
4:58pm
, prospects and financial condition.
Drug-related side effects could affect patient recruitment for clinical trials, the ability of enrolled patients
F-1/A
ALVO
Alvotech
13 Sep 22
Registration statement (foreign) (amended)
5:19pm
recruitment for clinical trials, the ability of enrolled patients to complete Alvotech’s studies or result in potential product liability claims against
F-1/A
msvzd 2hf
27 Jul 22
Registration statement (foreign) (amended)
5:13pm
F-1
nfy3a2ff5exmk1fxxp
22 Jul 22
Registration statement (foreign)
4:42pm
F-1
7adhx1u
14 Jul 22
Registration statement (foreign)
5:28pm
6-K
EX-99.1
u9g7azz etg3a
21 Jun 22
Current report (foreign)
4:06pm
425
csg67nvzyc2e
17 May 22
Business combination disclosure
9:01am
424B3
8gj sz7n50j77
10 May 22
Prospectus supplement
5:27pm
F-4/A
3zjnvkmy tplkb
10 May 22
Registration of securities (foreign) (amended)
8:06am
F-4/A
pagc56
2 May 22
Registration of securities (foreign) (amended)
7:38am
F-4/A
cso2sgs
19 Apr 22
Registration of securities (foreign) (amended)
5:17pm
F-4/A
f68ud2ebg296 rarmif
4 Apr 22
Registration of securities (foreign) (amended)
8:24am
425
mxdb20i
23 Mar 22
Business combination disclosure
5:03pm
425
rmk87nlcyibl8o4w
23 Mar 22
Business combination disclosure
4:05pm
F-4/A
9xblzikjb
14 Mar 22
Registration of securities (foreign) (amended)
4:49pm
425
8wdz qweawlr1w
14 Feb 22
Business combination disclosure
9:25pm
F-4/A
69938eao
4 Feb 22
Registration of securities (foreign) (amended)
8:58pm